Virology
病毒学
基本信息
- 批准号:7685030
- 负责人:
- 金额:$ 18.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-15 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressArtsBiological AssayCell LineClinicalConsultationsContainmentDevelopmentEngineeringEnsureEnvironmentEquipmentFacultyFee-for-Service PlansFosteringGoalsGrantHIVHuman ResourcesImmunologicsImmunologyKnowledgeLaboratoriesLifeMethodsMissionMolecularMolecular BiologyNatureOperative Surgical ProceduresPathogenesisPhasePlasmidsPoliciesProteinsQuality ControlReagentRecombinant ProteinsRecombinantsResearchResearch PersonnelResourcesSafetyServicesSiteStrategic PlanningStructureSupervisionTechniquesTechnology TransferTrainingTraining and EducationVaccine ResearchViralViral VectorWorkbasecostexperiencegene cloninggenetically modified cellslaboratory facilitymultidisciplinaryprogramsprotein expressionsafety practicesuccesstoolvirologyvirus culture
项目摘要
The goals of the VC are to enable, broaden and enhance HIV/AIDS research by providing state-of-the-art BSL-2-3
laboratory facilities and equipment, experienced and dedicated professional staff, education, training, virology-specific
research materials and assays and protein expression capabilities, all to support multidisciplinary, investigator-initiated
basic and clinical HIV/AIDS research. Each of our specific aims represent significant value-added to HIV/AIDS
research and the overall CFAR mission as they (i) enable live HIV research among all UAB investigators, (ii) foster the
development of HIV/AIDS research by new investigators, (iii) broaden the research capabilities among CFAR faculty,
and (iv) encourage research that is translational and multidisciplinary in nature. The services of VC are integral to the
AIDS Center as they provide critical support to numerous multidisciplinary basic and clinical HIV/AIDS research
programs. The specific aims for the VC are as follows:
1. To provide and maintain state-of-the-art BSL 2-3 laboratory facilities that are necessary to conduct
"live" HIV research.
2. To provide safety education and training, and ongoing supervision for all faculty and staff that work in
the BSL 2-3 Laboratory.
3. To augment AIDS research capabilities through consultation, assay-specific training, and provision of
standardized assays and defined molecular and virologic reagents.
4. To develop specialized genetically engineered tools and assays, including cell lines and viral vectors,
to help address new and important investigative challenges in HIV/AIDS research.
5. To continue to offer CFAR investigators the molecular biology services, reagents, and training, that
allow a rapid progression from cloning of genes to structure and/or function studies of the gene
product.
This renewal application reflects important changes that have occurred in the academic HIV/AIDS environment
nationally and at UAB since this grant was last competitively renewed. The critical services of two cores that were
previously operated independently, the Central Virus Culture Core and the Molecular Biology Core, have been
combined into a single core that is now referred to as the Virology Core (VC). This strategy is based on similarities in
the nature of virology services offered by the two previous cores and is meant to ensure that we are able to retain and
continue to provide critical value-added services, while maximizing proficient utilization of precious CFAR resources.
VC的目标是通过提供最先进的BSL-2-3来实现、扩大和加强艾滋病毒/艾滋病研究
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Christopher KAPPES其他文献
JOHN Christopher KAPPES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Christopher KAPPES', 18)}}的其他基金
The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue
跨性别男性男性化性别肯定激素治疗对子宫颈粘膜组织离体 HIV-1 感染易感性的影响
- 批准号:
10748946 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
10553626 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
10428455 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
9892706 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Analysis of human uterine mucosal cells as targets of HIV-1 infection
人类子宫粘膜细胞作为 HIV-1 感染靶点的分析
- 批准号:
8925576 - 财政年份:2015
- 资助金额:
$ 18.6万 - 项目类别:
Single cycle reporter assay for quantifying HIV-1 Nab
用于量化 HIV-1 Nab 的单循环报告基因检测
- 批准号:
6694007 - 财政年份:2003
- 资助金额:
$ 18.6万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 18.6万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 18.6万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 18.6万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 18.6万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 18.6万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 18.6万 - 项目类别:














{{item.name}}会员




